Pfizer announces leadership team for combined company after proposed Allergan merger

Pfizer announced in a press release its executive leadership team for the combined Pfizer and Allergan business following the close of the proposed merger of the companies.Through the closing of the transaction, Pfizer’s Global Innovative Pharma (GIP) business and its Vaccines Oncology and Consumer (VOC) business will operate separately under Albert Bourla, currently group president of VOC, according to the release. When the transaction is complete, the VOC and GIP businesses will combine, with Bourla becoming group president, Global Innovative Pharma, leading the combined businesses, according to the release.

Senate Health Committee passes Advancing Research for Neurological Diseases Act of 2015

The Senate Health Committee passed the “Advancing Research for Neurological Diseases Act of 2015” (S. 849)” on Tuesday, which will establish a national surveillance system for neurological diseases. The full Senate will now consider the bill. The objective of S. 849, sponsored by Sens. Johnny Isakson, R-Ga., and Chris Murphy, D-Conn., is to enhance and coordinate efforts to track the epidemiology of neurological diseases in the United States, such as multiple sclerosis and Parkinson’s disease.

Senate health committee passes Next Generation Researchers Act

The Senate health committee passed the Next Generation Researchers Act (S. 2014) with bipartisan support on Tuesday, which aims to increase opportunities for young researchers and attract them to the NIH. The full Senate will now consider the bill. “In order for America to out-innovate the rest of the world and create an economy built to last, we must protect and strengthen our investments in research, science and innovation. We can’t accomplish this without supporting and investing in the next generation of researchers,” Senator Tammy Baldwin, D-Wis., said in a press release. “This bipartisan legislation demonstrates a commitment to our future scientists by improving their opportunities at NIH.”